SPRO · Spero Therapeutics, Inc. · Documents
Market Cap
$70.46M
Shares
58.23M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-28 | — | |
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-12 | — | |
| 8-K | 2026-07-14 | 2026-07-08 | |
| 8-K | 2026-06-25 | 2026-06-23 | |
| 8-K | 2026-06-22 | 2026-06-17 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| DEF 14A | 2026-04-27 | 2026-06-23 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-01-30 | — | |
| 8-K | 2025-12-19 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-18 | 2025-06-12 | |
| 8-K | 2025-05-28 | — | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-04-28 | 2025-04-22 | |
| DEF 14A | 2025-04-28 | 2025-06-12 | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2025-02-28 | 2025-02-25 | |
| 8-K | 2025-01-10 | 2025-01-07 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-10-29 | — | |
| 8-K | 2024-09-10 | 2024-09-09 | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-08-05 | — | |
| 8-K | 2024-06-03 | 2024-05-29 | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| DEF 14A | 2024-04-16 | 2024-05-29 | |
| 8-K | 2024-03-29 | — | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| 8-K | 2024-03-13 | — | |
| 8-K | 2024-02-09 | 2024-02-05 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-05 | — | |
| 8-K | 2024-01-02 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-13 | — | |
| 8-K | 2023-11-01 | 2023-10-30 | |
| 8-K/A | 2023-10-16 | 2023-10-05 | |
| 8-K | 2023-10-10 | 2023-10-05 | |
| DEF 14A | 2023-09-01 | 2023-10-05 |
Showing 1–50 of 122 filings